SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3mca'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BX4_A_ADNA350_2 (PROTEIN (ADENOSINE KINASE))	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe)	3 / 3	LEU A 517 SER A 579 ASN B 254	None	0.76A	1bx4A-3mcaA: undetectable	1bx4A-3mcaA: 19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FM6_U_9CRU502_1 (RETINOIC ACID RECEPTOR RXR-ALPHA)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	ALA A 262 LEU A 180 VAL A 360 ILE A 362 LEU A 370	None	0.99A	1fm6U-3mcaA: undetectable	1fm6U-3mcaA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LIN_A_TFPA154_1 (CALMODULIN)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 7	GLU B 22 LEU B 106 GLU B 136 MET B 156	None	1.10A	1linA-3mcaB: undetectable	1linA-3mcaB: 14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UPF_A_URFA999_1 (URACIL PHOSPHORIBOSYLTRANSF ERASE)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 5	ALA B 225 TYR B 220 ILE B 221 ASP B 187	None	1.10A	1upfA-3mcaB: undetectable	1upfA-3mcaB: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UPF_C_URFC999_1 (URACIL PHOSPHORIBOSYLTRANSF ERASE)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 5	ALA B 225 TYR B 220 ILE B 221 ASP B 187	None	0.96A	1upfC-3mcaB: undetectable	1upfC-3mcaB: 21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B25_B_SAMB602_1 (HYPOTHETICAL PROTEIN)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	3 / 3	GLY B 353 GLU B 274 ASP B 357	None	0.65A	2b25B-3mcaB: undetectable	2b25B-3mcaB: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BFP_A_H4BA1290_1 (PTERIDINE REDUCTASE 1)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 8	SER A 164 LEU A 405 LEU A 469 LEU A 471	None	0.98A	2bfpA-3mcaA: undetectable	2bfpA-3mcaA: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BFP_C_H4BC1290_1 (PTERIDINE REDUCTASE 1)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 8	SER A 164 LEU A 405 LEU A 469 LEU A 471	None	0.92A	2bfpC-3mcaA: undetectable	2bfpC-3mcaA: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BFP_C_H4BC1290_1 (PTERIDINE REDUCTASE 1)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 8	SER A 441 LEU A 471 LEU A 407 LEU A 405	None	0.99A	2bfpC-3mcaA: undetectable	2bfpC-3mcaA: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BFP_D_H4BD1290_1 (PTERIDINE REDUCTASE 1)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 8	SER A 164 LEU A 405 LEU A 469 LEU A 471	None	0.89A	2bfpD-3mcaA: undetectable	2bfpD-3mcaA: 18.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BYO_A_LNLA1216_1 (LIPOPROTEIN LPPX)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 5	LEU A 571 ILE A 484 LEU A 485 SER A 486	None	0.93A	2byoA-3mcaA: undetectable	2byoA-3mcaA: 16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BYO_A_LNLA1217_1 (LIPOPROTEIN LPPX)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 4	VAL A 283 LEU A 387 ILE A 197 LEU A 194	None	0.98A	2byoA-3mcaA: undetectable	2byoA-3mcaA: 16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DCF_A_ACAA502_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	ALA A 262 VAL A 182 ASP A 287 SER A 270 ILE A 197	None	1.17A	2dcfA-3mcaA: undetectable	2dcfA-3mcaA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DM6_A_IMNA1401_1 (NADP-DEPENDENT LEUKOTRIENE B4 12-HYDROXYDEHYDROGEN ASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 10	ILE A 587 ALA A 565 ILE A 553 GLU A 501 ILE A 502	None	1.23A	2dm6A-3mcaA: undetectable 2dm6B-3mcaA: undetectable	2dm6A-3mcaA: 19.17 2dm6B-3mcaA: 19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_A_SAMA300_1 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe; Schizosaccharomy ces pombe)	3 / 3	SER B 360 HIS A 542 ASP B 288	None	0.81A	2oxtA-3mcaB: undetectable	2oxtA-3mcaB: 20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0M_A_KLNA1501_1 (CYTOCHROME P450 3A4)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 10	PHE A 555 ILE A 543 PHE A 574 LEU A 564 ILE A 507	None	1.33A	2v0mA-3mcaA: undetectable	2v0mA-3mcaA: 24.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Z0Y_A_SAMA300_0 (PUTATIVE UNCHARACTERIZED PROTEIN TTHA0657)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 9	ALA B 302 VAL B 299 LEU B 366 LEU B 311 ALA B 364	None	0.75A	2z0yA-3mcaB: undetectable	2z0yA-3mcaB: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Z0Y_B_SAMB400_0 (PUTATIVE UNCHARACTERIZED PROTEIN TTHA0657)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 9	ALA B 302 VAL B 299 LEU B 366 LEU B 311 ALA B 364	None	0.80A	2z0yB-3mcaB: undetectable	2z0yB-3mcaB: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A65_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	ALA A 262 VAL A 182 ASP A 287 SER A 270 ILE A 197	None	1.16A	3a65A-3mcaA: undetectable	3a65A-3mcaA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A65_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 12	ALA B 139 TYR B 271 VAL B 272 GLY B 138 ILE B 137	None	1.49A	3a65A-3mcaB: undetectable	3a65A-3mcaB: 22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CLB_B_TMQB612_1 (DHFR-TS)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	ASP A 392 SER A 321 ILE A 362 PRO A 361 ILE A 197	None	1.20A	3clbB-3mcaA: undetectable	3clbB-3mcaA: 20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_C_ROFC903_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	3 / 3	SER B 188 GLN B 191 PHE B 190	None	0.68A	3g4lC-3mcaB: undetectable	3g4lC-3mcaB: 24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_A_SAMA301_1 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	3 / 3	SER A 441 ASP A 483 ASP A 444	None	0.74A	3iv6A-3mcaA: undetectable	3iv6A-3mcaA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IV6_C_SAMC301_1 (PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	3 / 3	SER A 441 ASP A 483 ASP A 444	None	0.76A	3iv6C-3mcaA: undetectable	3iv6C-3mcaA: 19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IW1_A_ASDA1223_1 (CYTOCHROME P450 CYP125)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	PHE A 345 VAL A 342 ILE A 318 VAL A 320 VAL A 322	None	1.21A	3iw1A-3mcaA: undetectable	3iw1A-3mcaA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3M0W_E_P77E203_1 (PROTEIN S100-A4)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 8	ASP A 483 SER A 440 PHE A 560 LEU B 146	None	0.99A	3m0wE-3mcaA: undetectable 3m0wF-3mcaA: undetectable 3m0wG-3mcaA: undetectable 3m0wH-3mcaA: undetectable	3m0wE-3mcaA: 10.53 3m0wF-3mcaA: 10.53 3m0wG-3mcaA: 10.53 3m0wH-3mcaA: 10.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8X_B_NIMB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 12	HIS B 350 LEU B 266 ILE B 152 GLY B 138 ALA B 139	None	1.02A	3n8xB-3mcaB: undetectable	3n8xB-3mcaB: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8Z_B_FLPB1701_1 (PROSTAGLANDIN G/H SYNTHASE 1)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 12	LEU B 266 LEU B 202 ILE B 152 GLY B 138 ALA B 139	None	0.89A	3n8zB-3mcaB: undetectable	3n8zB-3mcaB: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RF4_A_FUNA201_1 (MACROPHAGE MIGRATION INHIBITORY FACTOR)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 11	SER B 314 ILE B 362 VAL B 299 PHE B 303 ILE B 308	None	1.17A	3rf4A-3mcaB: undetectable 3rf4C-3mcaB: undetectable	3rf4A-3mcaB: 15.94 3rf4C-3mcaB: 15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RF4_B_FUNB202_1 (MACROPHAGE MIGRATION INHIBITORY FACTOR)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 11	ILE B 308 SER B 314 ILE B 362 VAL B 299 PHE B 303	None	1.19A	3rf4A-3mcaB: undetectable 3rf4B-3mcaB: undetectable	3rf4A-3mcaB: 15.94 3rf4B-3mcaB: 15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RF4_C_FUNC203_1 (MACROPHAGE MIGRATION INHIBITORY FACTOR)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 11	ILE B 308 SER B 314 ILE B 362 VAL B 299 PHE B 303	None	1.22A	3rf4B-3mcaB: undetectable 3rf4C-3mcaB: undetectable	3rf4B-3mcaB: 15.94 3rf4C-3mcaB: 15.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HVC_B_HFGB1602_1 (BIFUNCTIONAL GLUTAMATE/PROLINE--T RNA LIGASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe; Schizosaccharomy ces pombe)	4 / 5	HIS B 251 GLU B 255 ARG A 577 HIS B 244	None	1.38A	4hvcB-3mcaB: undetectable	4hvcB-3mcaB: 20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NKX_C_STRC601_2 (STEROID 17-ALPHA-HYDROXYLASE /17,20 LYASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 5	ILE A 451 ARG B 171 ASP A 410 VAL A 430	None	1.19A	4nkxC-3mcaA: undetectable	4nkxC-3mcaA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NKX_D_STRD601_2 (STEROID 17-ALPHA-HYDROXYLASE /17,20 LYASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 5	ILE A 451 ARG B 171 ASP A 410 VAL A 430	None	1.21A	4nkxD-3mcaA: undetectable	4nkxD-3mcaA: 20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NTX_A_AMRA509_1 (ACID-SENSING ION CHANNEL 1 BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 6	ASP B 357 ASP B 315 ASN B 31 ARG B 319	None	1.14A	4ntxA-3mcaB: undetectable 4ntxC-3mcaB: undetectable	4ntxA-3mcaB: 22.25 4ntxC-3mcaB: 17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1Z_A_MXMA807_1 (PROSTAGLANDIN G/H SYNTHASE 1)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	6 / 12	ILE A 273 VAL A 283 LEU A 284 LEU A 313 LEU A 310 LEU A 309	None	1.44A	4o1zA-3mcaA: undetectable	4o1zA-3mcaA: 20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RP8_C_ASCC501_0 (ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 12	THR B 157 ILE B 250 ILE B 256 ALA B 208 ILE B 152	None	0.97A	4rp8C-3mcaB: undetectable	4rp8C-3mcaB: 23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4X1I_B_LOCB502_2 (TUBULIN BETA CHAIN)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	5 / 12	LEU B 243 LEU B 257 ALA B 139 VAL B 141 ALA B 208	None	0.99A	4x1iB-3mcaB: undetectable	4x1iB-3mcaB: 24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4YVX_A_GMRA401_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	LEU A 378 TYR A 379 TRP A 330 SER A 363 SER A 331	None	1.42A	4yvxA-3mcaA: undetectable	4yvxA-3mcaA: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZP0_A_DXCA500_0 (MULTIDRUG TRANSPORTER MDFA)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 10	ASP A 392 LEU A 201 LEU A 370 GLY A 195 MET A 198	None	1.45A	4zp0A-3mcaA: undetectable	4zp0A-3mcaA: 23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DZK_1_BEZ1801_0 (ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1 ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 BEZ-LEU-LEU)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	3 / 3	LEU A 576 PHE A 505 ILE A 575	None	0.47A	5dzk1-3mcaA: undetectable 5dzkF-3mcaA: undetectable 5dzkM-3mcaA: undetectable	5dzk1-3mcaA: 4.35 5dzkF-3mcaA: 15.71 5dzkM-3mcaA: 15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESK_A_1YNA701_2 (LANOSTEROL 14-ALPHA DEMETHYLASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 4	ALA A 427 PRO A 396 LEU A 180 HIS A 179	None	1.19A	5eskA-3mcaA: undetectable	5eskA-3mcaA: 22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IEP_A_VDYA201_1 (CDL2.3B)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	LEU A 346 PHE A 352 LEU A 394 THR A 183 LEU A 387	None	1.19A	5iepA-3mcaA: undetectable	5iepA-3mcaA: 12.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KKZ_A_ASCA1004_0 (CYTOCHROME B UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 6	HIS A 358 VAL A 360 TYR A 382 GLN A 393	None	1.42A	5kkzA-3mcaA: undetectable 5kkzG-3mcaA: undetectable	5kkzA-3mcaA: 21.10 5kkzG-3mcaA: 15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OF1_A_SALA301_1 (SPORE COAT-ASSOCIATED PROTEIN N)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	4 / 5	ALA B 147 VAL B 140 PHE B 185 ILE B 193	None	1.04A	5of1A-3mcaB: undetectable	5of1A-3mcaB: 13.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_A_CVIA301_1 (REGULATORY PROTEIN TETR)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	4 / 8	GLY A 428 ARG A 452 VAL A 425 ASP A 465	None	1.00A	5vlmA-3mcaA: undetectable	5vlmA-3mcaA: 15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BRD_C_RFPC502_1 (RIFAMPIN MONOOXYGENASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	VAL A 286 VAL A 181 GLY A 301 PHE A 293 GLY A 189	None	1.06A	6brdC-3mcaA: undetectable	6brdC-3mcaA: 9.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BXM_A_SAMA402_0 (DIPHTHAMIDE BIOSYNTHESIS ENZYME DPH2)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	5 / 12	LEU A 521 GLY A 522 LEU A 436 ILE A 409 ASP A 410	None	1.14A	6bxmA-3mcaA: 2.7	6bxmA-3mcaA: 17.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CLX_A_SAMA401_0 (O-METHYLTRANSFERASE)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN PROTEIN DOM34 (Schizosaccharomy ces pombe; Schizosaccharomy ces pombe)	5 / 12	ASP B 357 ALA B 363 GLY A 514 SER A 554 ASP B 378	None	1.30A	6clxA-3mcaB: undetectable	6clxA-3mcaB: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D9K_F_ACTF802_0 (UNCHARACTERIZED PROTEIN)	3mca	PROTEIN DOM34 (Schizosaccharomy ces pombe)	3 / 3	TYR B 282 ALA B 363 LEU B 359	None	0.75A	6d9kF-3mcaB: 5.3	6d9kF-3mcaB: 19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G1P_B_ACTB403_0 (ADP-RIBOSYLHYDROLASE LIKE 2)	3mca	ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN (Schizosaccharomy ces pombe)	3 / 3	PHE A 505 ARG A 546 GLN A 503	None	0.87A	6g1pB-3mcaA: undetectable	6g1pB-3mcaA: 19.44

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BX4_A_ADNA350_2","PROTEIN (ADENOSINE KINASE)","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe",3,"LEU A 517;SER A 579;ASN B 254","None","0.76A","1bx4A-3mcaA:undetectable","1bx4A-3mcaA:19.59"],["1FM6_U_9CRU502_1","RETINOIC ACID RECEPTOR RXR-ALPHA","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"ALA A 262;LEU A 180;VAL A 360;ILE A 362;LEU A 370","None","0.99A","1fm6U-3mcaA:undetectable","1fm6U-3mcaA:18.89"],["1LIN_A_TFPA154_1","CALMODULIN","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",4,"GLU B  22;LEU B 106;GLU B 136;MET B 156","None","1.10A","1linA-3mcaB:undetectable","1linA-3mcaB:14.62"],["1UPF_A_URFA999_1","URACIL PHOSPHORIBOSYLTRANSFERASE","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",4,"ALA B 225;TYR B 220;ILE B 221;ASP B 187","None","1.10A","1upfA-3mcaB:undetectable","1upfA-3mcaB:21.07"],["1UPF_C_URFC999_1","URACIL PHOSPHORIBOSYLTRANSFERASE","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",4,"ALA B 225;TYR B 220;ILE B 221;ASP B 187","None","0.96A","1upfC-3mcaB:undetectable","1upfC-3mcaB:21.07"],["2B25_B_SAMB602_1","HYPOTHETICAL PROTEIN","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",3,"GLY B 353;GLU B 274;ASP B 357","None","0.65A","2b25B-3mcaB:undetectable","2b25B-3mcaB:22.22"],["2BFP_A_H4BA1290_1","PTERIDINE REDUCTASE 1","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"SER A 164;LEU A 405;LEU A 469;LEU A 471","None","0.98A","2bfpA-3mcaA:undetectable","2bfpA-3mcaA:18.37"],["2BFP_C_H4BC1290_1","PTERIDINE REDUCTASE 1","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"SER A 164;LEU A 405;LEU A 469;LEU A 471","None","0.92A","2bfpC-3mcaA:undetectable","2bfpC-3mcaA:18.37"],["2BFP_C_H4BC1290_1","PTERIDINE REDUCTASE 1","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"SER A 441;LEU A 471;LEU A 407;LEU A 405","None","0.99A","2bfpC-3mcaA:undetectable","2bfpC-3mcaA:18.37"],["2BFP_D_H4BD1290_1","PTERIDINE REDUCTASE 1","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"SER A 164;LEU A 405;LEU A 469;LEU A 471","None","0.89A","2bfpD-3mcaA:undetectable","2bfpD-3mcaA:18.37"],["2BYO_A_LNLA1216_1","LIPOPROTEIN LPPX","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"LEU A 571;ILE A 484;LEU A 485;SER A 486","None","0.93A","2byoA-3mcaA:undetectable","2byoA-3mcaA:16.98"],["2BYO_A_LNLA1217_1","LIPOPROTEIN LPPX","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"VAL A 283;LEU A 387;ILE A 197;LEU A 194","None","0.98A","2byoA-3mcaA:undetectable","2byoA-3mcaA:16.98"],["2DCF_A_ACAA502_1","6-AMINOHEXANOATE-DIMER HYDROLASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"ALA A 262;VAL A 182;ASP A 287;SER A 270;ILE A 197","None","1.17A","2dcfA-3mcaA:undetectable","2dcfA-3mcaA:22.35"],["2DM6_A_IMNA1401_1","NADP-DEPENDENT LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE;NADP-DEPENDENT LEUKOTRIENE B4 12-HYDROXYDEHYDROGENASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"ILE A 587;ALA A 565;ILE A 553;GLU A 501;ILE A 502","None","1.23A","2dm6A-3mcaA:undetectable;2dm6B-3mcaA:undetectable","2dm6A-3mcaA:19.17;2dm6B-3mcaA:19.17"],["2OXT_A_SAMA300_1","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe;Schizosaccharomyces pombe",3,"SER B 360;HIS A 542;ASP B 288","None","0.81A","2oxtA-3mcaB:undetectable","2oxtA-3mcaB:20.94"],["2V0M_A_KLNA1501_1","CYTOCHROME P450 3A4","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"PHE A 555;ILE A 543;PHE A 574;LEU A 564;ILE A 507","None","1.33A","2v0mA-3mcaA:undetectable","2v0mA-3mcaA:24.15"],["2Z0Y_A_SAMA300_0","PUTATIVE UNCHARACTERIZED PROTEIN TTHA0657","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"ALA B 302;VAL B 299;LEU B 366;LEU B 311;ALA B 364","None","0.75A","2z0yA-3mcaB:undetectable","2z0yA-3mcaB:22.39"],["2Z0Y_B_SAMB400_0","PUTATIVE UNCHARACTERIZED PROTEIN TTHA0657","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"ALA B 302;VAL B 299;LEU B 366;LEU B 311;ALA B 364","None","0.80A","2z0yB-3mcaB:undetectable","2z0yB-3mcaB:22.39"],["3A65_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"ALA A 262;VAL A 182;ASP A 287;SER A 270;ILE A 197","None","1.16A","3a65A-3mcaA:undetectable","3a65A-3mcaA:22.35"],["3A65_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"ALA B 139;TYR B 271;VAL B 272;GLY B 138;ILE B 137","None","1.49A","3a65A-3mcaB:undetectable","3a65A-3mcaB:22.00"],["3CLB_B_TMQB612_1","DHFR-TS","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"ASP A 392;SER A 321;ILE A 362;PRO A 361;ILE A 197","None","1.20A","3clbB-3mcaA:undetectable","3clbB-3mcaA:20.52"],["3G4L_C_ROFC903_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",3,"SER B 188;GLN B 191;PHE B 190","None","0.68A","3g4lC-3mcaB:undetectable","3g4lC-3mcaB:24.78"],["3IV6_A_SAMA301_1","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",3,"SER A 441;ASP A 483;ASP A 444","None","0.74A","3iv6A-3mcaA:undetectable","3iv6A-3mcaA:19.46"],["3IV6_C_SAMC301_1","PUTATIVE ZN-DEPENDENT ALCOHOL DEHYDROGENASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",3,"SER A 441;ASP A 483;ASP A 444","None","0.76A","3iv6C-3mcaA:undetectable","3iv6C-3mcaA:19.46"],["3IW1_A_ASDA1223_1","CYTOCHROME P450 CYP125","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"PHE A 345;VAL A 342;ILE A 318;VAL A 320;VAL A 322","None","1.21A","3iw1A-3mcaA:undetectable","3iw1A-3mcaA:21.64"],["3M0W_E_P77E203_1","PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4;PROTEIN S100-A4","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe",4,"ASP A 483;SER A 440;PHE A 560;LEU B 146","None","0.99A","3m0wE-3mcaA:undetectable;3m0wF-3mcaA:undetectable;3m0wG-3mcaA:undetectable;3m0wH-3mcaA:undetectable","3m0wE-3mcaA:10.53;3m0wF-3mcaA:10.53;3m0wG-3mcaA:10.53;3m0wH-3mcaA:10.53"],["3N8X_B_NIMB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"HIS B 350;LEU B 266;ILE B 152;GLY B 138;ALA B 139","None","1.02A","3n8xB-3mcaB:undetectable","3n8xB-3mcaB:20.71"],["3N8Z_B_FLPB1701_1","PROSTAGLANDIN G\/H SYNTHASE 1","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"LEU B 266;LEU B 202;ILE B 152;GLY B 138;ALA B 139","None","0.89A","3n8zB-3mcaB:undetectable","3n8zB-3mcaB:20.71"],["3RF4_A_FUNA201_1","MACROPHAGE MIGRATION INHIBITORY FACTOR;MACROPHAGE MIGRATION INHIBITORY FACTOR","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"SER B 314;ILE B 362;VAL B 299;PHE B 303;ILE B 308","None","1.17A","3rf4A-3mcaB:undetectable;3rf4C-3mcaB:undetectable","3rf4A-3mcaB:15.94;3rf4C-3mcaB:15.94"],["3RF4_B_FUNB202_1","MACROPHAGE MIGRATION INHIBITORY FACTOR;MACROPHAGE MIGRATION INHIBITORY FACTOR","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"ILE B 308;SER B 314;ILE B 362;VAL B 299;PHE B 303","None","1.19A","3rf4A-3mcaB:undetectable;3rf4B-3mcaB:undetectable","3rf4A-3mcaB:15.94;3rf4B-3mcaB:15.94"],["3RF4_C_FUNC203_1","MACROPHAGE MIGRATION INHIBITORY FACTOR;MACROPHAGE MIGRATION INHIBITORY FACTOR","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"ILE B 308;SER B 314;ILE B 362;VAL B 299;PHE B 303","None","1.22A","3rf4B-3mcaB:undetectable;3rf4C-3mcaB:undetectable","3rf4B-3mcaB:15.94;3rf4C-3mcaB:15.94"],["4HVC_B_HFGB1602_1","BIFUNCTIONAL GLUTAMATE\/PROLINE--TRNA LIGASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe;Schizosaccharomyces pombe",4,"HIS B 251;GLU B 255;ARG A 577;HIS B 244","None","1.38A","4hvcB-3mcaB:undetectable","4hvcB-3mcaB:20.15"],["4NKX_C_STRC601_2","STEROID 17-ALPHA-HYDROXYLASE\/17,20 LYASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe",4,"ILE A 451;ARG B 171;ASP A 410;VAL A 430","None","1.19A","4nkxC-3mcaA:undetectable","4nkxC-3mcaA:20.93"],["4NKX_D_STRD601_2","STEROID 17-ALPHA-HYDROXYLASE\/17,20 LYASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe",4,"ILE A 451;ARG B 171;ASP A 410;VAL A 430","None","1.21A","4nkxD-3mcaA:undetectable","4nkxD-3mcaA:20.93"],["4NTX_A_AMRA509_1","ACID-SENSING ION CHANNEL 1;BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",4,"ASP B 357;ASP B 315;ASN B  31;ARG B 319","None","1.14A","4ntxA-3mcaB:undetectable;4ntxC-3mcaB:undetectable","4ntxA-3mcaB:22.25;4ntxC-3mcaB:17.46"],["4O1Z_A_MXMA807_1","PROSTAGLANDIN G\/H SYNTHASE 1","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",6,"ILE A 273;VAL A 283;LEU A 284;LEU A 313;LEU A 310;LEU A 309","None","1.44A","4o1zA-3mcaA:undetectable","4o1zA-3mcaA:20.12"],["4RP8_C_ASCC501_0","ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"THR B 157;ILE B 250;ILE B 256;ALA B 208;ILE B 152","None","0.97A","4rp8C-3mcaB:undetectable","4rp8C-3mcaB:23.38"],["4X1I_B_LOCB502_2","TUBULIN BETA CHAIN","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",5,"LEU B 243;LEU B 257;ALA B 139;VAL B 141;ALA B 208","None","0.99A","4x1iB-3mcaB:undetectable","4x1iB-3mcaB:24.03"],["4YVX_A_GMRA401_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"LEU A 378;TYR A 379;TRP A 330;SER A 363;SER A 331","None","1.42A","4yvxA-3mcaA:undetectable","4yvxA-3mcaA:20.54"],["4ZP0_A_DXCA500_0","MULTIDRUG TRANSPORTER MDFA","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"ASP A 392;LEU A 201;LEU A 370;GLY A 195;MET A 198","None","1.45A","4zp0A-3mcaA:undetectable","4zp0A-3mcaA:23.40"],["5DZK_1_BEZ1801_0","ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 1;ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2;BEZ-LEU-LEU","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",3,"LEU A 576;PHE A 505;ILE A 575","None","0.47A","5dzk1-3mcaA:undetectable;5dzkF-3mcaA:undetectable;5dzkM-3mcaA:undetectable","5dzk1-3mcaA:4.35;5dzkF-3mcaA:15.71;5dzkM-3mcaA:15.88"],["5ESK_A_1YNA701_2","LANOSTEROL 14-ALPHA DEMETHYLASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"ALA A 427;PRO A 396;LEU A 180;HIS A 179","None","1.19A","5eskA-3mcaA:undetectable","5eskA-3mcaA:22.97"],["5IEP_A_VDYA201_1","CDL2.3B","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"LEU A 346;PHE A 352;LEU A 394;THR A 183;LEU A 387","None","1.19A","5iepA-3mcaA:undetectable","5iepA-3mcaA:12.44"],["5KKZ_A_ASCA1004_0","CYTOCHROME B;UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"HIS A 358;VAL A 360;TYR A 382;GLN A 393","None","1.42A","5kkzA-3mcaA:undetectable;5kkzG-3mcaA:undetectable","5kkzA-3mcaA:21.10;5kkzG-3mcaA:15.20"],["5OF1_A_SALA301_1","SPORE COAT-ASSOCIATED PROTEIN N","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",4,"ALA B 147;VAL B 140;PHE B 185;ILE B 193","None","1.04A","5of1A-3mcaB:undetectable","5of1A-3mcaB:13.05"],["5VLM_A_CVIA301_1","REGULATORY PROTEIN TETR","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",4,"GLY A 428;ARG A 452;VAL A 425;ASP A 465","None","1.00A","5vlmA-3mcaA:undetectable","5vlmA-3mcaA:15.20"],["6BRD_C_RFPC502_1","RIFAMPIN MONOOXYGENASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"VAL A 286;VAL A 181;GLY A 301;PHE A 293;GLY A 189","None","1.06A","6brdC-3mcaA:undetectable","6brdC-3mcaA:9.27"],["6BXM_A_SAMA402_0","DIPHTHAMIDE BIOSYNTHESIS ENZYME DPH2","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",5,"LEU A 521;GLY A 522;LEU A 436;ILE A 409;ASP A 410","None","1.14A","6bxmA-3mcaA:2.7","6bxmA-3mcaA:17.73"],["6CLX_A_SAMA401_0","O-METHYLTRANSFERASE","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN;PROTEIN DOM34","Schizosaccharomyces pombe;Schizosaccharomyces pombe",5,"ASP B 357;ALA B 363;GLY A 514;SER A 554;ASP B 378","None","1.30A","6clxA-3mcaB:undetectable","6clxA-3mcaB:21.45"],["6D9K_F_ACTF802_0","UNCHARACTERIZED PROTEIN","3mca","PROTEIN DOM34","Schizosaccharomyces pombe",3,"TYR B 282;ALA B 363;LEU B 359","None","0.75A","6d9kF-3mcaB:5.3","6d9kF-3mcaB:19.90"],["6G1P_B_ACTB403_0","ADP-RIBOSYLHYDROLASE LIKE 2","3mca","ELONGATION FACTOR 1 ALPHA-LIKE PROTEIN","Schizosaccharomyces pombe",3,"PHE A 505;ARG A 546;GLN A 503","None","0.87A","6g1pB-3mcaA:undetectable","6g1pB-3mcaA:19.44"]]